Matches in SemOpenAlex for { <https://semopenalex.org/work/W2184732912> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2184732912 abstract "Bromocriptine, an ergot derivative, is an agonist at the dopamine 2 receptor and a sympatholytic. It is a well established drug in Parkinsonism, hyperprolactinaemia and acromegaly and it has various other clinical indications like induction of ovulation in female infertility. Bromocriptine has been evaluated in alloxan induced diabetic rats for its anti-hyperglycaemic effect with and without simultaneous use of glipizide.Diabetes was induced in albino rats by giving a single subcutaneous injection of alloxan in a dose of 150 mg/kg body weight. After 72 hours of giving alloxan injection, depending upon their blood glucose levels (350mg/dl and above), the rats were included into the study and they were divided into four groups, each comprising of 6 rats (n=24): Group 1 which was taken as control was given distilled water. Group 2 was treated with glipizide, a standard drug. Group 3 was treated with the test drug, bromocriptine and Group 4 was treated with sub therapeutic doses of test and standard drugs. The drugs were given to the diabetic rats once daily by oral route for 30 consecutive days, in order to assess their effects in terms of reduction in blood glucose levels. Blood glucose was estimated on 0(th), 10(th), 20(th), and 30(th) days of the study at fixed time intervals.Bromocriptine, which was used alone, lowered the blood glucose levels appreciably; whereas the concomitant administration of bromocriptine and glipizide in sub therapeutic doses produced a much more appreciable reduction. The results which were obtained in the group which received simultaneous administration of test and standard drugs in sub therapeutic doses were comparable to those of the group which received reference drug, glipizide. Hence, it can be concluded that bromocriptine may serve as a valuable adjunct to available anti-diabetic medication." @default.
- W2184732912 created "2016-06-24" @default.
- W2184732912 creator A5029399080 @default.
- W2184732912 creator A5035090125 @default.
- W2184732912 creator A5060005549 @default.
- W2184732912 creator A5089624957 @default.
- W2184732912 date "2013-01-01" @default.
- W2184732912 modified "2023-10-14" @default.
- W2184732912 title "Bromocriptine, a Dopamine (D 2 ) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub–Therapeutic Doses to Ameliorate Hyperglycaemia" @default.
- W2184732912 cites W1525713084 @default.
- W2184732912 cites W1771441866 @default.
- W2184732912 cites W1998237043 @default.
- W2184732912 cites W2002999049 @default.
- W2184732912 cites W2004192853 @default.
- W2184732912 cites W2024529821 @default.
- W2184732912 cites W2069183963 @default.
- W2184732912 cites W2071275007 @default.
- W2184732912 cites W2089311855 @default.
- W2184732912 cites W2107582181 @default.
- W2184732912 cites W2116196704 @default.
- W2184732912 cites W2142332909 @default.
- W2184732912 cites W2156422741 @default.
- W2184732912 cites W2161902574 @default.
- W2184732912 cites W2412121367 @default.
- W2184732912 cites W2493336461 @default.
- W2184732912 cites W2581791997 @default.
- W2184732912 doi "https://doi.org/10.7860/jcdr/2013/5803.3347" @default.
- W2184732912 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3809633" @default.
- W2184732912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24179894" @default.
- W2184732912 hasPublicationYear "2013" @default.
- W2184732912 type Work @default.
- W2184732912 sameAs 2184732912 @default.
- W2184732912 citedByCount "5" @default.
- W2184732912 countsByYear W21847329122015 @default.
- W2184732912 countsByYear W21847329122017 @default.
- W2184732912 countsByYear W21847329122018 @default.
- W2184732912 countsByYear W21847329122019 @default.
- W2184732912 crossrefType "journal-article" @default.
- W2184732912 hasAuthorship W2184732912A5029399080 @default.
- W2184732912 hasAuthorship W2184732912A5035090125 @default.
- W2184732912 hasAuthorship W2184732912A5060005549 @default.
- W2184732912 hasAuthorship W2184732912A5089624957 @default.
- W2184732912 hasBestOaLocation W21847329121 @default.
- W2184732912 hasConcept C120069818 @default.
- W2184732912 hasConcept C126322002 @default.
- W2184732912 hasConcept C134018914 @default.
- W2184732912 hasConcept C170493617 @default.
- W2184732912 hasConcept C2776856834 @default.
- W2184732912 hasConcept C2778258207 @default.
- W2184732912 hasConcept C2778938600 @default.
- W2184732912 hasConcept C2779064019 @default.
- W2184732912 hasConcept C2779555806 @default.
- W2184732912 hasConcept C2781005915 @default.
- W2184732912 hasConcept C513476851 @default.
- W2184732912 hasConcept C555293320 @default.
- W2184732912 hasConcept C71315377 @default.
- W2184732912 hasConcept C71924100 @default.
- W2184732912 hasConcept C98274493 @default.
- W2184732912 hasConceptScore W2184732912C120069818 @default.
- W2184732912 hasConceptScore W2184732912C126322002 @default.
- W2184732912 hasConceptScore W2184732912C134018914 @default.
- W2184732912 hasConceptScore W2184732912C170493617 @default.
- W2184732912 hasConceptScore W2184732912C2776856834 @default.
- W2184732912 hasConceptScore W2184732912C2778258207 @default.
- W2184732912 hasConceptScore W2184732912C2778938600 @default.
- W2184732912 hasConceptScore W2184732912C2779064019 @default.
- W2184732912 hasConceptScore W2184732912C2779555806 @default.
- W2184732912 hasConceptScore W2184732912C2781005915 @default.
- W2184732912 hasConceptScore W2184732912C513476851 @default.
- W2184732912 hasConceptScore W2184732912C555293320 @default.
- W2184732912 hasConceptScore W2184732912C71315377 @default.
- W2184732912 hasConceptScore W2184732912C71924100 @default.
- W2184732912 hasConceptScore W2184732912C98274493 @default.
- W2184732912 hasLocation W21847329121 @default.
- W2184732912 hasLocation W21847329122 @default.
- W2184732912 hasLocation W21847329123 @default.
- W2184732912 hasLocation W21847329124 @default.
- W2184732912 hasOpenAccess W2184732912 @default.
- W2184732912 hasPrimaryLocation W21847329121 @default.
- W2184732912 hasRelatedWork W1983918007 @default.
- W2184732912 hasRelatedWork W1985786391 @default.
- W2184732912 hasRelatedWork W2006136814 @default.
- W2184732912 hasRelatedWork W2007184064 @default.
- W2184732912 hasRelatedWork W2027355567 @default.
- W2184732912 hasRelatedWork W2027596383 @default.
- W2184732912 hasRelatedWork W2028697314 @default.
- W2184732912 hasRelatedWork W2079101059 @default.
- W2184732912 hasRelatedWork W2120403613 @default.
- W2184732912 hasRelatedWork W2184732912 @default.
- W2184732912 isParatext "false" @default.
- W2184732912 isRetracted "false" @default.
- W2184732912 magId "2184732912" @default.
- W2184732912 workType "article" @default.